Detalhe da pesquisa
1.
MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common ß-chain cytokine receptor endocytosis.
Blood
; 139(5): 761-778, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34780648
2.
shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistance.
Blood
; 125(11): 1772-81, 2015 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25573989
3.
BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationships.
Blood
; 121(3): 489-98, 2013 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-23223358
4.
The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemia.
Blood
; 118(19): 5250-4, 2011 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21908430
5.
A novel AGGF1-PDGFRb fusion in pediatric T-cell acute lymphoblastic leukemia.
Haematologica
; 103(2): e87-e91, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29284681
6.
Spatially resolved transcriptomics for evaluation of intracranial vessels in a rabbit model: Proof of concept.
Interv Neuroradiol
; 29(3): 307-314, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35306920
7.
Real-Time Monitoring and Modulation of Blood Pressure in a Rabbit Model of Ischemic Stroke.
J Vis Exp
; (192)2023 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36847368
8.
Evaluation of methemoglobin as an intravascular contrast agent: T1 relaxation time effect in a rabbit model.
Magn Reson Imaging
; 103: 1-7, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37392804
9.
Non-invasive central nervous system assessment of a porcine model of neuropathic pain demonstrates increased latency of somatosensory-evoked potentials.
J Neurosci Methods
; 396: 109934, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37524248
10.
Rabbit models of intracranial atherosclerotic disease for pathological validation of vessel wall MRI.
Neuroradiol J
; 34(3): 193-199, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33325806
11.
SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA.
Blood Cancer Discov
; 2(3): 266-287, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34027418
12.
Apolipoprotein E knockout rabbit model of intracranial atherosclerotic disease.
Animal Model Exp Med
; 3(2): 208-213, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32613180
13.
Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants.
Cancer Cell
; 36(4): 431-443.e5, 2019 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31543464
14.
A Novel Crizotinib-Resistant Solvent-Front Mutation Responsive to Cabozantinib Therapy in a Patient with ROS1-Rearranged Lung Cancer.
Clin Cancer Res
; 22(10): 2351-8, 2016 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26673800
15.
Limited efficacy of BMS-911543 in a murine model of Janus kinase 2 V617F myeloproliferative neoplasm.
Exp Hematol
; 43(7): 537-45.e1-11, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25912019
16.
Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia.
Leukemia
; 29(3): 586-597, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25134459
17.
BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia.
Cancer Cell
; 26(3): 428-442, 2014 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25132497
18.
Threshold levels of ABL tyrosine kinase inhibitors retained in chronic myeloid leukemia cells determine their commitment to apoptosis.
Cancer Res
; 73(11): 3356-70, 2013 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23576564
19.
Pushing the limits of targeted therapy in chronic myeloid leukaemia.
Nat Rev Cancer
; 12(8): 513-26, 2012 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-22825216
20.
Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia.
Cancer Cell
; 20(6): 715-27, 2011 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-22169110